Treasury Secretary Steven Mnuchin is raising red flags ahead of Facebook's proposed cryptocurrency launch.Marketsread more
Some White House officials expect the Cabinet secretary, who has known the president for years, to depart as soon as this summer.Politicsread more
David Marcus, the head of Facebook's digital currency project, said the company expects Libra will drive more advertising revenue for the company.Technologyread more
Epstein is accused of sexually exploiting dozens of underage girls from 2002 through 2005 at his New York and Florida residences. He is a former friend of Presidents Donald...Politicsread more
When you think of Prime Day, you might be thinking about deals on Instant Pots and Amazon Echo devices — not half-off dresses and designer heels. But the market for apparel...Retailread more
Amazon workers in Minnesota and Germany are striking as Prime Day kicks off, in a stand against working conditions and wage practices. The action in Minnesota represents the...Retailread more
The Guggenheim CIO says he had been approached by the White House about possibly joining the Federal Reserve.The Fedread more
Joe Lonsdale says his fellow Palantir co-founder Peter Thiel was "courageous" for speaking out against Alphabet's Google.Technologyread more
Wall Street analysts say it is increasingly possible the Trump administration will try using a stronger weapon in the currency wars than just presidential tweets.Market Insiderread more
In his prepared testimony for Tuesday's Senate banking committee hearing, Facebook's David Marcus tells lawmakers that the Libra currency will be secure.Technologyread more
Twitter has rebuilt its website from the ground up for the first time ever, here's what it looks like.Technologyread more
Check out which companies are making headlines before the bell:
Mylan — Mylan said it would launch an EpiPen generic at a 50 percent discount to the branded product's list price. The pharmaceutical firm has been under amid the rapid price increases for the EpiPen.
Roche Holding — The Swiss firm was granted Food and Drug Administration emergency use approval for its Zika test.
Charter Communications — Guggenheim resumed coverage of Charter's shares with a "buy" rating and a $300 price target, saying the firm's financial growth potential remains underappreciated. "We expect: 1) strong subscriber and revenue growth as the company takes market share, 2) margin improvement as operating efficiencies are realized, and 3) incremental investor interest, particularly if the company is added to the S&P500 index, to be the key share drivers over the next 12 months," Guggenheim said in a note.
Sanofi, Regeneron — The two firms jointly announced positive Phase 3 results for Praluent, a drug aimed at reducing cholesterol levels. Sanofi and Regeneron said in a statement Praulent reduced LDL cholesterol by about 50 percent during trials.
T-Mobile — Wells Fargo Securities upgraded the telecom company's stock to "outperform" from "market perform" as free cash flow should see a "significant ramp-up" next year. "This — more than any other metric — will likely become a key focus for investors as we move into late 2016 and 2017," Wells said.
United Technologies — United Technologies reiterated its full-year guidance in an 8-K filing released Monday. The firm sees adjusted earnings per share in a range of $6.45 to $6.60 and sales between $57 billion and $58 billion.
Square — BTIG downgraded the payments firm's stock to "neutral" from "buy" and removed its $12 price target, saying it sees the stock as more "fairly valued" after rising nearly 40 percent since June 27.
KeyCorp — Piper Jaffray downgraded KeyCorp's stock to "neutral" from "overweight," citing concerns the firm may not meet Wall Street's earnings estimates for fiscal year 2017 and 2018. "Thus, we would expect the stock to have a difficult time outperforming peers as estimates continue to move lower over the next several months," Piper said.